ESC 365 - LDL goals and inflammation. From basic science to clinical practice.

ESC Premium Access

LDL goals and inflammation. From basic science to clinical practice.

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Symposium

Date: 26 August 2018

Time: 16:45 - 17:45

Session

5 presentations in this session

New aspects of the patho-biology of atherosclerosis: the role of lipids and inflammation.

Speaker: Professor A. Catapano (Milan, IT)

Current LDL-cholesterol goals- Are they appropriate?

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Identification of new molecule to mediate binding of PCSK9 and LDL-receptor - New insight on action mechanism of PCSK9 to degrade LDL-R

Speaker: Doctor H. Kim (Seoul, KR)

Future directions for research into LDL lowering, anti-inflammatory drugs and interactions.

Speaker: Professor S. Kim (Seoul, KR)

Panel discussion.

4 speakers from this session

Professor Alberico Catapano

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)

34 presentations

3 followers

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)

23 presentations

0 follower

Doctor Hyo-Soo Kim

Seoul National University Hospital, Seoul (Korea (Republic of))

3 presentations

0 follower

Professor Sang-Hyun Kim

Hospital Boramae , Seoul (Korea (Republic of))

1 presentation

0 follower

This platform is supported by